Home Applications 204209 Application 204209
Type ANDA
Sponsor LARKEN LABS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE TABLET;ORAL 325MG;30MG;16MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A204209-001 ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE 325MG;30MG;16MG TABLET / ORAL 2016-09-30
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A204209-001 ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE 325MG;30MG;16MG TABLET / ORAL 2016-09-30 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A204209-001 ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE 325MG;30MG;16MG TABLET / ORAL 2016-09-30 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A204209-001 ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE 325MG;30MG;16MG TABLET / ORAL 2016-09-30 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A204209-001 ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE 325MG;30MG;16MG TABLET / ORAL 2016-09-30 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A204209-001 ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE 325MG;30MG;16MG TABLET / ORAL 2016-09-30 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 9 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 68047-720 Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Larken Laboratories Inc. ANDA Current 68047-720 Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Larken Laboratories Inc. ANDA Current 68047-720 Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Larken Laboratories Inc. ANDA Current 70362-730 DVORAH acetaminophen, caffeine and dihydrocodeine bitartrate Skylar Laboratories, LLC ANDA Current 70362-730 DVORAH acetaminophen, caffeine and dihydrocodeine bitartrate Skylar Laboratories, LLC ANDA Current 70362-730 DVORAH acetaminophen, caffeine and dihydrocodeine bitartrate Skylar Laboratories, LLC ANDA Current 70569-152 DVORAH acetaminophen, caffeine and dihydrocodeine bitartrate Phlight Pharma, LLC ANDA Current 70569-152 DVORAH acetaminophen, caffeine and dihydrocodeine bitartrate Phlight Pharma, LLC ANDA Current 71993-300 Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Atland Pharmaceuticals, LLC ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 76103 ORIG 2023-11-02 45590 ORIG 2016-10-05